Neuralstem Cell Transplant for Post-Stroke Symptom
Neuralstem Inc has a peer-reviewed paper published talking about the improvements of rat brain after ischemic-stroke with the use of NSI566 neural stemcells.
Neuralstem is currently conducting a Phase II NSI-566 clinical trial in amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) in three U.S. sites, as well as a Phase I/II to treat post-stroke motor deficit in China, through its wholly-owned subsidiary, Neuralstem China. The company also has been approved by the FDA to commence a trial with the same cells to treat chronic spinal cord injury.
This is only one of the great research projects going on in the biotech hub Rockville Maryland.. where I will be for the next year!
I can’t wait.
73 notes
marithadotws reblogged this from mediclopedia
frizzyfro liked this
picturesfor4g-blog liked this mokabrain reblogged this from mediclopedia
subatomicdoc liked this
kimberlynbabykim-blog liked this
freuds-kitten-blog liked this
mifernandescosta liked this
m-sofuckingcool reblogged this from mediclopedia
silverlight-moonlight liked this
thefunsideoflearning reblogged this from mediclopedia
hoshilin liked this
quexopafriend-blog liked this
colorblind525 reblogged this from mediclopedia
isittheendyet liked this
asahk liked this
melyizahs liked this
ann-oyingmuch reblogged this from swimminghuman dcrianpavus liked this
dingonhealth liked this covarnthings-blog liked this
francesurgery liked this
prestige-subaru-fm liked this
soccerstud22 liked this
grilledcheeseandwhine reblogged this from cytofocus - grilledcheeseandwhine liked this
cherrysorote-blog liked this
- omg-suicida liked this
psyxrebeldreams liked this ironicdrummerboy reblogged this from mediclopedia
med-sci-land-art-blog reblogged this from mediclopedia
pallaka liked this
ciscandocinza liked this
mediclopedia posted this
- Show more notes